Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

被引：1
|
作者：
Qin, Hong [1 ]
You, Changqiao [1 ]
Yan, Feng [1 ]
Tan, Kefang [1 ]
Xu, Changgen [1 ]
Zhao, Rui [2 ]
Ekpo, Marlene Davis [2 ]
Tan, Songwen [2 ]
机构：
[1] NanHua Biomed CO Ltd, Res & Dev Dept, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
natural killer (NK) cells; immunosenescence; immunotherapy; cancer; chemotherapy; biotherapeutics; CAR-NK CELLS; CORD BLOOD; ADOPTIVE TRANSFER; CYTOKINE RELEASE; IN-VIVO; IMMUNOTHERAPY; ACTIVATION; EXPANSION; THERAPY; TRANSPLANTATION;
D O I：
10.3389/fonc.2022.1062765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Early Cellular Pathways of Mouse Natural Killer Cell Development
    Sitnicka, Ewa
    JOURNAL OF INNATE IMMUNITY, 2011, 3 (04) : 329 - 336
  • [22] Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide
    Karvouni, Maria
    Vidal-Manrique, Marcos
    Susek, Katharina H.
    Hussain, Alamdar
    Gilljam, Mari
    Zhang, Yanliang
    Gray, J. Dixon
    Lund, Johan
    Kaufmann, Gunnar
    Ljunggren, Hans-Gustaf
    Ji, Henry
    Lundqvist, Andreas
    Wagner, Arnika K.
    Guo, Wenzhong
    Alici, Evren
    CYTOTHERAPY, 2023, 25 (07) : 763 - 772
  • [23] The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
    Yao, Pin
    Liu, Ya-Guang
    Huang, Gang
    Hao, Liangchun
    Wang, Runan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [24] Deficits in our understanding of natural killer cell development in mouse and human
    Schorr, Christopher
    Krishnan, Maya Shraddha
    Capitano, Maegan
    CURRENT OPINION IN HEMATOLOGY, 2023, 30 (04) : 106 - 116
  • [25] Requirements for human natural killer cell development informed by primary immunodeficiency
    Mace, Emily M.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 16 (06) : 541 - 548
  • [26] Regulation of natural killer T-cell development by deubiquitinase CYLD
    Lee, Andrew J.
    Zhou, Xiaofei
    Chang, Mikyoung
    Hunzeker, John
    Bonneau, Robert H.
    Zhou, Dapeng
    Sun, Shao-Cong
    EMBO JOURNAL, 2010, 29 (09) : 1600 - 1612
  • [27] SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses
    Molfetta, Rosa
    Petillo, Sara
    Cippitelli, Marco
    Paolini, Rossella
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [28] Control of early stages in invariant natural killer T-cell development
    Hu, Taishan
    Gimferrer, Idoia
    Alberola-Ila, Jose
    IMMUNOLOGY, 2011, 134 (01) : 1 - 7
  • [29] Effects of epigenetic therapy on natural killer cell function and development in hematologic malignancy
    Lordo, Matthew R.
    Stiff, Andrew R.
    Oakes, Christopher C.
    Mundy-Bosse, Bethany L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2023, 113 (05) : 518 - 524
  • [30] Impact of β2 integrin deficiency on mouse natural killer cell development and function
    Crozat, Karine
    Eidenschenk, Celine
    Jaeger, Baptiste N.
    Krebs, Philippe
    Guia, Sophie
    Beutler, Bruce
    Vivier, Eric
    Ugolini, Sophie
    BLOOD, 2011, 117 (10) : 2874 - 2882
12345